Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02614378 · ClinicalTrials.gov registry record · NA
Abortive Effect of an Ear Insufflator on Migraine
A NA study, sponsored by Carrick Institute for Graduate Studies.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT02614378 is a NA study that has completed, run by Carrick Institute for Graduate Studies. The registered enrollment target is 58 participants.
The verdict
NCT02614378, a NA study, has completed, sponsored by Carrick Institute for Graduate Studies.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
Evaluate the effectiveness of air insufflation in aborting (stopping) an acute episode of migraine and compare it with a placebo effect of using the same procedure but without active insufflation. The insufflation will be used when the subject is experiencing an acute episode of migraine to determine its ability to reduce, if not to completely eliminate the migraine symptoms. Subjects receiving the placebo treatment will be offered the active treatment during the subsequent episode of migraine.
Interventions
- PROCEDURE placebo
- PROCEDURE air insufflation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02614378
The ClinicalTrials.gov registry entry for NCT02614378 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carrick Institute for Graduate Studies, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT02614378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02614378 about?
NCT02614378 is a clinical study titled "Abortive Effect of an Ear Insufflator on Migraine". Evaluate the effectiveness of air insufflation in aborting (stopping) an acute episode of migraine and compare it with a placebo effect of using the same procedure but without active insufflation. The insufflation will be used when the subject is experiencing an acute episode of migraine to determin...
What is the current status of trial NCT02614378?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2015-11. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02614378?
The interventions under investigation include: placebo (PROCEDURE), air insufflation (PROCEDURE).
Who is sponsoring clinical trial NCT02614378?
This trial is sponsored by Carrick Institute for Graduate Studies, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.